Breaking Finance News

Fresenius (ETR:FRE) has been upgraded to Buy in a report by DZ BANK today.

Only yesterday Fresenius (ETR:FRE) traded 0.00% even at 69.28EUR. The company’s 50-day moving average is 0.00EUR and its two hundred day moving average is 0.00EUR. With the last stock close up 0.00% from the 200-day moving average, compared with the S&P 500 which has fallen -0.01% over the same time. Trade volume was held steady, with 0 shares of FRE changing hands on par with the typical 0 shares..

DZ BANK has upgraded Fresenius(ETR:FRE) to Buy in a statement released 9/16/2016.

Previously on 9/15/2016, Warburg Research reported about Fresenius(ETR:FRE) bumped the target price from 0.00EUR to 73.40EUR. At the time, this suggested an upside of 0.04%.

See Graphic Below:

Fresenius (ETR:FRE)

Fresenius has a one-year low of 0.00EUR and a 52 week high of 0.00EUR. The company’s market cap is presently 0.0 EUR.

General Company Details For Fresenius (ETR:FRE)

Fresenius SE & Co KGaA is a health care company. It operates in the healthcare sector and offers products and services for dialysis, hospitals and outpatient medical care. It focuses on the hospital operations and offers engineering and services for hospitals and other health care facilities. The Company’s operating segments include Fresenius Medical Care; Fresenius Kabi; Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment provides dialysis care and dialysis products for patients with chronic kidney failure. The Fresenius Kabi segment is engaged in provision of intravenously administered drugs (IV drugs), infusion therapies, and clinical nutrition and outpatient care. The Fresenius Helios segment is a private hospital operator and operates 72 clinics. The Fresenius Vamed segment provides engineering and services for hospitals and other health care facilities internationally.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *